Published in Hum Reprod on April 19, 2011
Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology. Eur J Hum Genet (2013) 0.87
Cross-border reproductive care among French patients: experiences in Greece, Spain and Belgium. Hum Reprod (2013) 0.83
Issues arising when crossing a border to give birth: an exploratory study on the French-Belgian border. Facts Views Vis Obgyn (2014) 0.78
Attitudes toward Regulations of Reproductive Care in the European Union: A Comparison between Travellers for Cross-Border Reproductive Care and Citizens of the Local Country. Facts Views Vis Obgyn (2016) 0.75
"One for Sorrow, Two for Joy?": American embryo transfer guideline recommendations, practices, and outcomes for gestational surrogate patients. J Assist Reprod Genet (2017) 0.75
Giving oocytes to women in need: permitted, forbidden, or pressured? A commentary. Isr J Health Policy Res (2012) 0.75
"Now we feel like we did everything we could": A qualitative study into the experiences of Dutch patients who travelled to Belgium for infertility treatment. Facts Views Vis Obgyn (2014) 0.75
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med (1998) 4.08
Reducing the time of sperm-oocyte interaction in human in-vitro fertilization improves the implantation rate. Hum Reprod (1996) 2.35
Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod (2012) 2.28
Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15
Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod (2010) 2.04
Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis (2012) 1.94
Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod (2013) 1.91
Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod (2008) 1.78
I. The moral status of the pre-implantation embryo. Hum Reprod (2001) 1.73
Decline in semen concentration and morphology in a sample of 26,609 men close to general population between 1989 and 2005 in France. Hum Reprod (2012) 1.67
The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update (2012) 1.62
ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod (2008) 1.59
Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertil Steril (1999) 1.53
Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod (2004) 1.53
Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertil Steril (1997) 1.49
Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J Cell Biol (2000) 1.43
The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem (1998) 1.41
RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ (2013) 1.36
Cell membrane permeabilization and cellular collapse, followed by loss of dehydrogenase activity: early events in tumour necrosis factor-induced cytotoxicity. Cytokine (1993) 1.34
Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod (2007) 1.28
TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm (1997) 1.27
Cross border reproductive care in six European countries. Hum Reprod (2010) 1.25
Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Hum Reprod (2012) 1.23
Ooplasmic and nuclear transfer to prevent mitochondrial DNA disorders: conceptual and normative issues. Hum Reprod Update (2008) 1.21
The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost (2006) 1.18
ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October 2008. Hum Reprod (2010) 1.17
Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod (1999) 1.15
Incidence of chromosomal abnormalities from a morphologically normal cohort of embryos in poor-prognosis patients. J Assist Reprod Genet (1998) 1.15
Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy? Hum Reprod (1997) 1.14
New enrichment method for isolation of pathogenic Yersinia enterocolitica serogroup O:3 from pork. Appl Environ Microbiol (1988) 1.12
Sperm:oocyte ratios in an in vitro fertilization (IVF) program. J Assist Reprod Genet (1994) 1.09
Rescue of implantation potential in embryos with poor prognosis by assisted zona hatching. Hum Reprod (1998) 1.06
Prolonged sperm-oocyte exposure and high sperm concentration affect human embryo viability and pregnancy rate. Hum Reprod (1996) 1.06
PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and Fragile-X syndrome. Mol Cell Endocrinol (2001) 1.02
ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010. Hum Reprod (2014) 1.00
Possible interchromosomal effect in embryos generated by gametes from translocation carriers. Hum Reprod (2002) 1.00
ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum Reprod (2008) 0.99
Ethics of modifying the mitochondrial genome. J Med Ethics (2010) 0.99
Chromosomal abnormalities in embryos. Mol Cell Endocrinol (2001) 0.98
Quiescence-inducing and antiapoptotic activities of IL-15 enhance secondary CD4+ T cell responsiveness to antigen. J Immunol (1998) 0.97
ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod (2007) 0.97
Reproductive tourism as moral pluralism in motion. J Med Ethics (2002) 0.96
PGD to reduce reproductive risk: the case of mitochondrial DNA disorders. Hum Reprod (2008) 0.96
Oocyte cryopreservation for age-related fertility loss. Hum Reprod (2012) 0.95
Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders. Hum Reprod Update (2007) 0.94
ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod (2006) 0.94
Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod (2010) 0.93
Preimplantation genetic diagnosis of aneuploidy and male infertility. Int J Androl (1997) 0.93
ESHRE Task Force on Ethics and Law 12: oocyte donation for non-reproductive purposes. Hum Reprod (2007) 0.92
Oocyte euploidy, pronuclear zygote morphology and embryo chromosomal complement. Hum Reprod (2006) 0.92
Providing infertility treatment in resource-poor countries. Hum Reprod (2009) 0.90
Oocyte donation for stem cell research. Hum Reprod (2006) 0.90
Infertility patients' beliefs about their embryos and their disposition preferences. Hum Reprod (2009) 0.90
Impact of blastomere biopsy and cryopreservation techniques on human embryo viability. Hum Reprod (1999) 0.88
ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues. Hum Reprod (2014) 0.88
Diagnostic testicular biopsy and cryopreservation of testicular tissue as an alternative to repeated surgical openings in the treatment of azoospermic men. Hum Reprod (1999) 0.88
ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons. Hum Reprod (2013) 0.87
Predicting aneuploidy in human oocytes: key factors which affect the meiotic process. Hum Reprod (2010) 0.87
The minisequencing method: an alternative strategy for preimplantation genetic diagnosis of single gene disorders. Mol Hum Reprod (2003) 0.87
The successful use of human amniotic fluid for mouse embryo culture and human in vitro fertilization, embryo culture, and transfer. Fertil Steril (1986) 0.86
Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryos. Prenat Diagn (1998) 0.86
A study of factors affecting the success of human fertilization in vitro. I. Influence of ovarian stimulation upon the number and condition of oocytes collected. Biol Reprod (1983) 0.85
Advantages of day 4 embryo transfer in patients undergoing preimplantation genetic diagnosis of aneuploidy. J Assist Reprod Genet (1999) 0.84
Double locus analysis of chromosome 21 for preimplantation genetic diagnosis of aneuploidy. Prenat Diagn (2001) 0.84
Intrafamilial medically assisted reproduction. Hum Reprod (2011) 0.84
ESHRE Task Force on Ethics and Law 10: surrogacy. Hum Reprod (2005) 0.83
Improved cleavage rate of human embryos cultured in antibiotic-free medium. Hum Reprod (1996) 0.83
Preimplantation diagnosis after assisted reproduction techniques for genetically-determined male infertility. J Endocrinol Invest (2000) 0.83
Birth of a healthy infant after conception with round spermatids isolated from cryopreserved testicular tissue. Fertil Steril (1999) 0.83
To continue or discontinue storage of cryopreserved embryos? Patients' decisions in view of their child wish. Hum Reprod (2011) 0.82
Role of aneuploidy on embryo implantation. Gynecol Obstet Invest (2007) 0.82
The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles. Hum Reprod (2005) 0.82
Socio-demographic and fertility-related characteristics and motivations of oocyte donors in eleven European countries. Hum Reprod (2014) 0.82
The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy. Mol Cell Endocrinol (2001) 0.81
Parenthood should be regarded as a right. Arch Dis Child (2005) 0.81
Reflections by patients who undergo IVF on the use of their supernumerary embryos for science. Reprod Biomed Online (2010) 0.80
[Factors affecting the cumulative live birth rate in IVF cycles. Retrospective analysis of a 1001 couples cohort]. Gynecol Obstet Fertil (2012) 0.80
Paternal contribution to aneuploidy in preimplantation embryos. Reprod Biomed Online (2009) 0.80
Patients' conceptualization of cryopreserved embryos used in their fertility treatment. Hum Reprod (2009) 0.80
Nuclear transfer to prevent mitochondrial DNA disorders: revisiting the debate on reproductive cloning. Reprod Biomed Online (2010) 0.80
Taskforce 5: preimplantation genetic diagnosis. Hum Reprod (2003) 0.80
Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women. Fertil Steril (1983) 0.80
Human embryo co-culture: results of a randomized prospective study. Int J Fertil Menopausal Stud (1996) 0.80
A caspase-activated factor (CAF) induces mitochondrial membrane depolarization and cytochrome c release by a nonproteolytic mechanism. J Exp Med (1998) 0.79
Trends in embryo disposition decisions: patients' responses to a 15-year mailing program. Hum Reprod (2011) 0.79
Medical therapy of oligoasthenospermia associated with left varicocele. BJU Int (2003) 0.79
Clinical value of preimplantation genetic diagnosis. Placenta (2003) 0.79
II. The cryopreservation of human embryos. Hum Reprod (2001) 0.78
The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme. Hum Reprod (1990) 0.78
Cryopreservation of biopsied embryos at the blastocyst stage. Hum Reprod (2006) 0.78
Early human pregnancy in vitro utilizing an artificially perfused uterus. Fertil Steril (1988) 0.78
Fertilization current in the human oocyte. Mol Reprod Dev (1994) 0.78